ANIK · Anika Therapeutics, Inc.
One customer — 53% of revenue (the three-months ended June 30, 2026)
“Revenue from the Company's sole significant customer, Johnson & Johnson MedTech ("J&J MedTech"), part of the Johnson & Johnson Medical Companies, as a percentage of the Company's total revenue was 53% and 50% for the three-months ended June 30, 2026, and 2025, respectively, and 50% for the six-months ended June 30, 2026, and 2025.”
One customer — 50% of revenue (the six-months ended June 30, 2026)
“Revenue from the Company's sole significant customer, Johnson & Johnson MedTech ("J&J MedTech"), part of the Johnson & Johnson Medical Companies, as a percentage of the Company's total revenue was 53% and 50% for the three-months ended June 30, 2026, and 2025, respectively, and 50% for the six-months ended June 30, 2026, and 2025.”
One customer — 50% of revenue (the six-months ended June 30, 2025)
“Revenue from the Company's sole significant customer, Johnson & Johnson MedTech ("J&J MedTech"), part of the Johnson & Johnson Medical Companies, as a percentage of the Company's total revenue was 53% and 50% for the three-months ended June 30, 2026, and 2025, respectively, and 50% for the six-months ended June 30, 2026, and 2025.”
One customer — 50% of revenue (the three-months ended June 30, 2025)
“Revenue from the Company's sole significant customer, Johnson & Johnson MedTech ("J&J MedTech"), part of the Johnson & Johnson Medical Companies, as a percentage of the Company's total revenue was 53% and 50% for the three-months ended June 30, 2026, and 2025, respectively, and 50% for the six-months ended June 30, 2026, and 2025.”
Transactions in this listed security by members of the U.S. Congress, disclosed under the STOCK Act. Lawmakers must report trades within 45 days, so the filing date can lag the trade itself.
| Date | Member | Position | Type | Owner | Amount | Filed | Lag |
|---|---|---|---|---|---|---|---|
| 2020-03-02 | Tom Malinowski | Representative | Buy Anika Therapeutics Inc. (ANIK) | — | $1K - $15K | 2021-03-05 | 368d late |
| 2020-02-28 | Tom Malinowski | Representative | Buy Anika Therapeutics Inc. (ANIK) | — | $1K - $15K | 2021-08-26 | 545d late |
| 2020-02-27 | Tom Malinowski | Representative | Buy Anika Therapeutics Inc. (ANIK) | — | $1K - $15K | 2021-08-26 | 546d late |
| 2020-02-26 | Tom Malinowski | Representative | Buy Anika Therapeutics Inc. (ANIK) | — | $0 - $15K | 2021-03-05 | 373d late |
| 2020-01-28 | Tom Malinowski | Representative | Sell Anika Therapeutics Inc. (ANIK) | — | $1K - $15K | 2021-08-26 | 576d late |